These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
194 related articles for article (PubMed ID: 8796933)
1. Study design for the evaluation of treatment. Morales AJ Semin Reprod Endocrinol; 1996 May; 14(2):111-8. PubMed ID: 8796933 [TBL] [Abstract][Full Text] [Related]
2. Selective exclusion of treatment arms in multi-arm randomized clinical trials. Law MG; Emery S Stat Med; 2003 Jan; 22(1):19-30. PubMed ID: 12486749 [TBL] [Abstract][Full Text] [Related]
3. Compliance in clinical trials: impact on design, analysis and interpretation. Pledger GW Epilepsy Res Suppl; 1988; 1():125-33. PubMed ID: 3072187 [TBL] [Abstract][Full Text] [Related]
4. Design, operation, and interpretation of clinical trials. Pihlstrom BL; Barnett ML J Dent Res; 2010 Aug; 89(8):759-72. PubMed ID: 20581353 [TBL] [Abstract][Full Text] [Related]
5. Beyond randomized controlled trials: a critical comparison of trials with nonrandomized studies. Sørensen HT; Lash TL; Rothman KJ Hepatology; 2006 Nov; 44(5):1075-82. PubMed ID: 17058242 [TBL] [Abstract][Full Text] [Related]
6. The effects of non-compliance on intent-to-treat analysis of equivalence trials. Sheng D; Kim MY Stat Med; 2006 Apr; 25(7):1183-99. PubMed ID: 16220491 [TBL] [Abstract][Full Text] [Related]
7. Design and analysis issues for economic analysis alongside clinical trials. Marshall DA; Hux M Med Care; 2009 Jul; 47(7 Suppl 1):S14-20. PubMed ID: 19536012 [TBL] [Abstract][Full Text] [Related]
8. Sample size determination for assessing equivalence based on proportion ratio under a randomized trial with non-compliance and missing outcomes. Lui KJ; Chang KC Stat Med; 2008 Jan; 27(1):47-67. PubMed ID: 17708514 [TBL] [Abstract][Full Text] [Related]
9. Design of treatment trials for functional gastrointestinal disorders. ; Irvine EJ; Whitehead WE; Chey WD; Matsueda K; Shaw M; Talley NJ; Veldhuyzen van Zanten SJ Gastroenterology; 2006 Apr; 130(5):1538-51. PubMed ID: 16678567 [TBL] [Abstract][Full Text] [Related]
10. Stopping clinical trials because of treatment ineffectiveness: a comparison of a futility design with a method of stochastic curtailment. Whitehead J; Matsushita T Stat Med; 2003 Mar; 22(5):677-87. PubMed ID: 12587099 [TBL] [Abstract][Full Text] [Related]
11. A practical limit to trials needed in one-person randomized controlled experiments. Alemi R; Alemi F Qual Manag Health Care; 2007; 16(2):130-4. PubMed ID: 17426611 [TBL] [Abstract][Full Text] [Related]
12. Designs for efficient clinical trials. Simon R Oncology (Williston Park); 1989 Jul; 3(7):43-9; discussion 51-3. PubMed ID: 2701811 [TBL] [Abstract][Full Text] [Related]
13. Size of treatment effects and their importance to clinical research and practice. Kraemer HC; Kupfer DJ Biol Psychiatry; 2006 Jun; 59(11):990-6. PubMed ID: 16368078 [TBL] [Abstract][Full Text] [Related]
14. Methodology of superiority vs. equivalence trials and non-inferiority trials. Christensen E J Hepatol; 2007 May; 46(5):947-54. PubMed ID: 17412447 [TBL] [Abstract][Full Text] [Related]
15. Enhancing the validity and utility of randomized clinical trials in addictions treatment research: I. Treatment implementation and research design. Del Boca FK; Darkes J Addiction; 2007 Jul; 102(7):1047-56. PubMed ID: 17567393 [TBL] [Abstract][Full Text] [Related]
16. Sample size estimation for GEE method for comparing slopes in repeated measurements data. Jung SH; Ahn C Stat Med; 2003 Apr; 22(8):1305-15. PubMed ID: 12687656 [TBL] [Abstract][Full Text] [Related]
17. General statistical design considerations of randomized clinical trials. Peduzzi P Prog Clin Biol Res; 1988; 264():61-70. PubMed ID: 3289035 [TBL] [Abstract][Full Text] [Related]